Anti-caking agent microsrystalline cellulose, Corn starch, MGCPQQ® disodium salt of pyrroloquinoline quinone, Surface finishing agent magnesium salts of fatty acids
1-2 tablets contain:
MGCPQQ® disodium salt of pyrroloquinoline quinone 10-20 mg
For adults 1-2 tablets a day. The daily dosage should not be exceeded.
Not recommended during pregnancy or breastfeeding.
Free from lactose, sweeteners, gluten and yeast. Suitable for vegans.
60 tablets/ 15 g
PQQ, or pyrroloquinoline quinone, is a water-soluble compound found from microbes in 1979. It can’t be produced by humans and although it is produced in small amounts by the gut microbes, it must be obtained predominantly from diet. Parsley, kiwi, green pepper, papaya and tofu are good sources of PQQ.
PQQ supports mitochondrial function. Mitochondria are responsible for the cellular energy metabolism, or cellular respiration. PQQ affects cell growth, development, differentiation and life span. PQQ has an effect mainly to brain health, but also on the metabolism of the whole body.
MGCPQQ®, is manufactured by the Japanese Mitsubishi Gas Chemical Company. MGCPQQ® is a water soluble compound produced by fermentation of Hyphomicrobium denitrificans strain CK-275. MGCPQQ® has received Novel Food status in the EU on 10.8.2018. It is the only PQQ that has a Novel Food status. The maximum daily dose is 20 mg.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.